News

After a prostate cancer diagnosis, the way your doctor describes your cancer can help you understand what to expect next.
Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS ...
Respiratory viruses such as influenza and COVID-19 can reactivate dormant breast cancer cells in the lungs, raising the risk ...
Dr. Jacob Sands explained that he believes patients should be having more personalized, nuanced conversations with their ...
Clearview Cancer Institute's new facility will offer new treatment technologies to the north Alabama region and double the total number of rooms it has currently spread across two locations, officials ...
Public awareness about the link between human papillomavirus, or HPV, and cancer is low. A doctor explains why its lifesaving ...
Five-year survival rates for people with lung cancer have doubled since the 1990s, but the disease still kills more patients ...
GAAP EPS was $(0.49) for Q2 2025, missing analyst estimates by 22.3%. Moleculin Biotech (NASDAQ:MBRX), a clinical-stage pharmaceutical developer focused on oncology, released its second quarter 2025 ...
Published in *Cell* on February 11, 2025, the study shows that tumors release chemokines, which circulate to the lungs and ...
A phase 1/2 trial reveals sacituzumab tirumotecan shows manageable toxicity and promising antitumor activity in patients with ...
“These results from EV-303 represent a breakthrough for cisplatin-ineligible patients with muscle-invasive bladder cancer, demonstrating the potential of PADCEV in combination with KEYTRUDA when used ...